CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
169 hedge funds and large institutions have $318M invested in Clovis Oncology, Inc. in 2020 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 55 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
169
Holders Change
+12
Holders Change %
+7.64%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
33
Increased
55
Reduced
42
Closed
20
Calls
$30.1M
Puts
$26.5M
Net Calls
+$3.53M
Net Calls Change
-$4.53M
Top Buyers
| 1 |
Morgan Stanley
New York
|
$13.3M |
| 2 |
N
Natixis
Paris,
France
|
$6.35M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
$5.83M |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
$4.41M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
$23.2M |
